Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer

NCT04983095 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

118

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer Metastatic
Radiation Therapy
Positron-Emission Tomography

Interventions

RADIATION: stereotactic body radiotherapy
COMBINATION_PRODUCT: androgen deprivation therapy
RADIATION: Radiotherapy

Sponsor

Karin Soderkvist

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]